592 related articles for article (PubMed ID: 8989345)
1. Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. The PREVENT Study Group.
Pediatrics; 1997 Jan; 99(1):93-9. PubMed ID: 8989345
[TBL] [Abstract][Full Text] [Related]
2. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.
Pediatrics; 1998 Sep; 102(3 Pt 1):531-7. PubMed ID: 9738173
[TBL] [Abstract][Full Text] [Related]
3. Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group.
Rodriguez WJ; Gruber WC; Welliver RC; Groothuis JR; Simoes EA; Meissner HC; Hemming VG; Hall CB; Lepow ML; Rosas AJ; Robertsen C; Kramer AA
Pediatrics; 1997 Mar; 99(3):454-61. PubMed ID: 9041304
[TBL] [Abstract][Full Text] [Related]
4. [Prophylaxis of respiratory syncytial virus (RSV) in preterm infants with/without bronchopulmonary dysplasia: hyperimmune globulin (RSV-IGIV) and palivizumab (MEDI-493)].
Resch B; Müller W
Klin Padiatr; 1999; 211(6):450-5. PubMed ID: 10592925
[TBL] [Abstract][Full Text] [Related]
5. Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants.
Pediatrics; 1998 Sep; 102(3):531-7. PubMed ID: 9724660
[TBL] [Abstract][Full Text] [Related]
6. Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease. The Cardiac Study Group.
Simoes EA; Sondheimer HM; Top FH; Meissner HC; Welliver RC; Kramer AA; Groothuis JR
J Pediatr; 1998 Oct; 133(4):492-9. PubMed ID: 9787686
[TBL] [Abstract][Full Text] [Related]
7. Respiratory syncytial virus immune globulin intravenous: indications for use. American Academy of Pediatrics Committee on Infectious Diseases, Committee on Fetus and Newborn.
Pediatrics; 1997 Apr; 99(4):645-50. PubMed ID: 9093323
[TBL] [Abstract][Full Text] [Related]
8. Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IGIV. American Academy of Pediatrics Committee on Infectious Diseases and Committee of Fetus and Newborn.
Pediatrics; 1998 Nov; 102(5):1211-6. PubMed ID: 9794957
[TBL] [Abstract][Full Text] [Related]
9. Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG). Respiratory Syncytial Virus Immune Globulin Study Group.
Groothuis JR; Simoes EA; Hemming VG
Pediatrics; 1995 Apr; 95(4):463-7. PubMed ID: 7700741
[TBL] [Abstract][Full Text] [Related]
10. Prophylaxis for respiratory syncytial virus with respiratory syncytial virus-immunoglobulin intravenous among preterm infants of thirty-two weeks gestation and less: reduction in incidence, severity of illness and cost.
Atkins JT; Karimi P; Morris BH; McDavid G; Shim S
Pediatr Infect Dis J; 2000 Feb; 19(2):138-43. PubMed ID: 10694001
[TBL] [Abstract][Full Text] [Related]
11. Role of antibody and use of respiratory syncytial virus (RSV) immune globulin to prevent severe RSV disease in high-risk children.
Groothuis JR
J Pediatr; 1994 May; 124(5 Pt 2):S28-32. PubMed ID: 8169755
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group.
Groothuis JR; Simoes EA; Levin MJ; Hall CB; Long CE; Rodriguez WJ; Arrobio J; Meissner HC; Fulton DR; Welliver RC
N Engl J Med; 1993 Nov; 329(21):1524-30. PubMed ID: 8413475
[TBL] [Abstract][Full Text] [Related]
13. Costs and benefits of respiratory syncytial virus immunoglobulin to prevent hospitalization for lower respiratory tract illness in very low birth weight infants.
O'Shea TM; Sevick MA; Givner LB
Pediatr Infect Dis J; 1998 Jul; 17(7):587-93. PubMed ID: 9686723
[TBL] [Abstract][Full Text] [Related]
14. Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children.
Rodriguez WJ; Gruber WC; Groothuis JR; Simoes EA; Rosas AJ; Lepow M; Kramer A; Hemming V
Pediatrics; 1997 Dec; 100(6):937-42. PubMed ID: 9374560
[TBL] [Abstract][Full Text] [Related]
15. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections.
American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn
Pediatrics; 2003 Dec; 112(6 Pt 1):1442-6. PubMed ID: 14654627
[TBL] [Abstract][Full Text] [Related]
16. Respiratory syncytial virus immune globulin intravenous.
Wandstrat TL
Ann Pharmacother; 1997 Jan; 31(1):83-8. PubMed ID: 8997472
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin for preventing respiratory syncytial virus infection.
Wang EE; Tang NK
Cochrane Database Syst Rev; 2000; (2):CD001725. PubMed ID: 10796658
[TBL] [Abstract][Full Text] [Related]
18. Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children.
Garegnani L; Styrmisdóttir L; Roson Rodriguez P; Escobar Liquitay CM; Esteban I; Franco JV
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013757. PubMed ID: 34783356
[TBL] [Abstract][Full Text] [Related]
19. Safety, tolerance and pharmacokinetics of a humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. MEDI-493 Study Group.
Subramanian KN; Weisman LE; Rhodes T; Ariagno R; Sánchez PJ; Steichen J; Givner LB; Jennings TL; Top FH; Carlin D; Connor E
Pediatr Infect Dis J; 1998 Feb; 17(2):110-5. PubMed ID: 9493805
[TBL] [Abstract][Full Text] [Related]
20. RSV-IGIV therapy: a cost/benefit analysis.
Thakur BK; Wu LR; Schaeufele JF
Pediatrics; 1997 Sep; 100(3 Pt 1):417-8. PubMed ID: 9304108
[No Abstract] [Full Text] [Related]
[Next] [New Search]
